Lim CED, Ng RWC, Cheng NCL, et al
The abdomen typically provides the fastest and most consistent absorption due to higher blood flow in that region, making it a preferred site for patients beginning treatment
The Obesema 0.25 mg pre-filled pen delivers a precise, once-weekly Semaglutide injection under the skin
The two GLP-1 receptor agonists covered in this guide have common side effects nausea, diarrhea, and vomiting but in the 2021 study weve referenced, semaglutide exhibited up to a 5% lower risk of nausea, 4% of diarrhea, and 2% of vomiting.3 Its lower side effect risk compared to tirzepatide is slight but clear
With no current approved treatments for this conditionwhich affects millions worldwidethese results could mark a turning point for patients suffering from this often silent but deadly disease